Charity Scripture - 01 Dec 2021 Form 4 Insider Report for BELLICUM PHARMACEUTICALS, INC

Role
Chief Development Officer
Signature
Charity Scripture
Issuer symbol
N/A
Transactions as of
01 Dec 2021
Net transactions value
+$259,500
Form type
4
Filing time
02 Dec 2021, 14:23:39 UTC
Next filing
16 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLCM Stock Option (right to buy) Award $259,500 +150,000 $1.73 150,000 01 Dec 2021 Common Stock 150,000 $1.73 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the stock option vest and become exercisable on December 1, 2022, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter.